LSE - Delayed Quote GBp
Bioventix PLC (BVXP.L)
As of 3:01 PM GMT. Market Open.
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
13,596.48
12,816.23
11,719.27
10,930.59
10,313.58
Cost of Revenue
850.45
828.41
710.45
817.45
821.82
Gross Profit
12,746.04
11,987.82
11,008.83
10,113.14
9,491.75
Operating Expense
1,992.68
1,917.79
1,828.16
1,731.49
1,510.43
Operating Income
10,753.36
10,070.03
9,180.67
8,381.65
7,981.32
Net Non Operating Interest Income Expense
157.88
101.09
4.50
30.63
41.07
Pretax Income
10,856.74
10,134.44
9,278.03
8,118.23
8,225.06
Tax Provision
2,191.27
1,762.20
1,603.87
1,386.88
1,022.36
Net Income Common Stockholders
8,665.48
8,372.24
7,674.15
6,731.35
7,202.70
Diluted NI Available to Com Stockholders
8,665.48
8,372.24
7,674.15
6,731.35
7,202.70
Basic EPS
1.66
1.61
1.47
1.29
1.39
Diluted EPS
1.63
1.58
1.46
1.28
1.38
Basic Average Shares
5,217.26
5,212.22
5,209.33
5,209.30
5,166.56
Diluted Average Shares
5,307.28
5,289.50
5,259.83
5,261.30
5,222.00
Total Operating Income as Reported
10,698.86
10,033.35
9,273.52
8,087.60
8,183.99
Total Expenses
2,843.12
2,746.20
2,538.60
2,548.94
2,332.25
Net Income from Continuing & Discontinued Operation
8,665.48
8,372.24
7,674.15
6,731.35
7,202.70
Normalized Income
8,665.48
8,372.24
7,674.15
6,731.35
7,202.70
Interest Income
157.88
101.09
4.80
30.63
41.07
Interest Expense
--
--
0.30
--
--
Net Interest Income
157.88
101.09
4.50
30.63
41.07
EBIT
10,817.78
10,134.44
9,278.33
8,118.23
7,981.32
EBITDA
10,940.65
10,263.67
9,421.72
8,253.33
8,114.89
Reconciled Cost of Revenue
850.45
828.41
710.45
817.45
821.82
Reconciled Depreciation
122.87
129.23
143.39
135.10
133.57
Net Income from Continuing Operation Net Minority Interest
8,665.48
8,372.24
7,674.15
6,731.35
7,202.70
Normalized EBITDA
10,940.65
10,263.67
9,421.72
8,253.33
8,114.89
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
6/30/2020 - 4/29/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
22UA.DU BioNTech SE
98.60
-1.25%
SBTX.L SkinBioTherapeutics plc
14.29
-3.13%
IBT.L International Biotechnology Ord
708.44
+0.92%
FUM.L Futura Medical plc
38.07
-0.87%
OXB.L Oxford Biomedica plc
413.00
-0.60%
AVCT.L Avacta Group Plc
51.44
+6.18%
PGEN Precigen, Inc.
0.9550
+6.69%
ZEAL.CO Zealand Pharma A/S
825.50
-3.68%
BAVA.CO Bavarian Nordic A/S
203.90
+1.95%
CPRX Catalyst Pharmaceuticals, Inc.
23.51
+3.52%